{"data":{"id":"us-tx/tex.-health-and-safety-code-597.052","jurisdiction":"us-tx","citation":"Tex. Health and Safety Code § 597.052","heading":"SCOPE OF CONSENT.","body":"(a) The committee or the surrogate decision-maker may consent to the release of records related to the client's condition or treatment to facilitate treatment to which the committee or surrogate decision-maker has consented.\n(b) The interdisciplinary team may consent to psychoactive medication subsequent to the initial consent for administration of psychoactive medication made by a surrogate consent committee in accordance with rules of the department until the expiration date of the consent.\n(c) Unless another decision-making mechanism is provided for by law, a client, a client's authorized surrogate decision-maker if available, or the client's interdisciplinary team may consent to decisions which involve risk to client protection and rights not specifically reserved to surrogate decision-makers or surrogate consent committees.\nAdded by Acts 1993, 73rd Leg., ch. 530, Sec. 1, eff. Aug. 30, 1993. Amended by Acts 1997, 75th Leg., ch. 450, Sec. 8, eff. Sept. 1, 1997. Reenacted by Acts 1999, 76th Leg., ch. 538, Sec. 1, eff. June 18, 1999.","path":["HEALTH AND SAFETY CODE","TITLE 7. MENTAL HEALTH AND INTELLECTUAL DISABILITY","SUBTITLE D. PERSONS WITH AN INTELLECTUAL DISABILITY ACT","CHAPTER 597. CAPACITY OF CLIENTS TO CONSENT TO TREATMENT","SUBCHAPTER C. SURROGATE CONSENT FOR ICF-IID CLIENTS"],"source_url":"https://statutes.capitol.texas.gov/Docs/HS/htm/HS.597.htm#597.052","current_through":"89th 2nd Called Legislative Session, 2025","vintage":"","retrieved_at":"2026-08-27T01:47:17Z","sha256":"9bcbeb384765947e8edf4dbb0bb80f521111d3639344e0a10d382af52d22003d","source_id":"us-tx","stale":false,"prev":"us-tx/tex.-health-and-safety-code-597.051","next":"us-tx/tex.-health-and-safety-code-597.053"},"notice":"GroundRules: Original legal text. Not legal advice."}